Adjuvant Autologous Tumour Cell-Lysate Vaccine versus No Adjuvant Treatment in Patients with M0 Renal Cell Carcinoma after Radical Nephrectomy: 3-Year Interim Analysis of a German Multicentre Phase-III Trial
1Department of Urology, University of Lübeck Medical School, Lübeck, Germany 2Department of Urology, St. Georg Hospital Leipzig, Leipzig, Germany 3Institute for Medical Statistics, University of Cologne Medical School, Cologne, Germany
